Patrick Mauro Investment Advisor INC. Makes New Investment in CME Group Inc. $CME

Patrick Mauro Investment Advisor INC. purchased a new position in CME Group Inc. (NASDAQ:CME) in the second quarter, HoldingsChannel reports. The firm purchased 52,702 shares of the financial services provider’s stock, valued at approximately $11,638,000. CME Group comprises 5.8% of Patrick Mauro Investment Advisor INC.’s investment portfolio, making the stock its 3rd biggest position.

Several other institutional investors and hedge funds have also made changes to their positions in CME. Northwestern Mutual Investment Management Company LLC raised its holdings in CME Group by 0.3% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group increased its position in shares of CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after purchasing an additional 37 shares during the period. Endowment Wealth Management Inc. increased its position in shares of CME Group by 4.4% during the 4th quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares during the period. NBT Bank N A NY raised its stake in shares of CME Group by 2.3% in the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock worth $492,000 after buying an additional 38 shares in the last quarter. Finally, Resonant Capital Advisors LLC boosted its stake in CME Group by 3.8% during the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock valued at $317,000 after buying an additional 39 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director William R. Shepard bought 325 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $266.94 on Thursday. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company has a 50-day moving average of $250.89 and a two-hundred day moving average of $279.81. The stock has a market cap of $95.99 billion, a price-to-earnings ratio of 22.64, a PEG ratio of 3.16 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the firm posted $2.96 earnings per share. The firm’s quarterly revenue was up .8% compared to the same quarter last year. On average, equities research analysts expect that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s payout ratio is presently 44.11%.

Analyst Ratings Changes

Several brokerages have commented on CME. Bank of America boosted their price target on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research report on Thursday, July 23rd. Raymond James Financial reaffirmed an “outperform” rating and issued a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a report on Thursday, June 18th. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Finally, Deutsche Bank Aktiengesellschaft cut CME Group from a “buy” rating to a “hold” rating and dropped their price target for the company from $286.00 to $270.00 in a report on Wednesday. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $288.56.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.